scholarly journals Spontaneous Closure of the Arterial Duct after Transcatheter Closure Attempt in Preterm Infants

Children ◽  
2021 ◽  
Vol 8 (12) ◽  
pp. 1138
Author(s):  
Mathilde Méot ◽  
Raymond N. Haddad ◽  
Juliana Patkai ◽  
Ibrahim Abu Zahira ◽  
Anna Di Marzio ◽  
...  
Keyword(s):  
Preterm Infants ◽  
Premature Infants ◽  
Transcatheter Closure ◽  
Spontaneous Closure ◽  
Device Closure ◽  
Catheterization Laboratory ◽  
Surgical Ligation ◽  
Arterial Duct ◽  
Closure Group ◽  
Patent Arterial Duct

(1) Background: Transcatheter closure of the patent arterial duct (TCPDA) in preterm infants is an emerging procedure. Patent arterial duct (PDA) spontaneous closure after failed TCPDA attempts is seen but reasons and outcomes are not reported; (2) Methods: We retrospectively included all premature infants <2 kg with abandoned TCPDA procedures from our institutional database between September 2017 and August 2021. Patients’ data and outcomes were reviewed; (3) Results: The procedure was aborted in 14/130 patients referred for TCPDA. Two patients had spasmed PDA upon arrival in the catheterization laboratory and had no intervention. One patient had ductal spasm after guidewire cross. Four patients had unsuitable PDA size/shape for closure. In seven patients, device closure was not possible without causing obstruction on adjacent vessels. Among the 12 patients with attempted TCPDA, five had surgery on a median of 3 days after TCPDA and seven had a spontaneous PDA closure within a median of 3 days after the procedure. Only the shape of the PDA differed between the surgical ligation group (short and conical) and spontaneous closure group (F-type); (4) Conclusions: In the case of TCPDA failure, mechanically induced spontaneous closure may occur early after the procedure. Surgical ligation should be postponed when clinically tolerated.

scholarly journals Patent Arterial Duct and Vascular Ring in a Premature Infant

2013 ◽  
Vol 52 (189) ◽  
pp. 275-276 ◽  
Author(s):  
Anil Bhattarai ◽  
Vladimiro Vida ◽  
Silvia Ricato ◽  
Sabrina Salvadori ◽  
Giovanni Stellin
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Premature Infant ◽  
Premature Infants ◽  
Congenital Heart ◽  
Vascular Ring ◽  
Surgical Ligation ◽  
Arterial Duct ◽  
Operative Findings ◽  
Patent Arterial Duct

We report a case of a 750 grams premature female who was scheduled for surgical ligation of a patent arterial duct. Intra-operative findings showed a patent arterial duct in association to a retro-esophageal aortic arch creating a complete vascular ring around the trachea, which was successfully divided. A vascular ring should be ruled-out in premature infants prior to ductal ligation at bidimensional echocardiography. Keywords: congenital heart disease; premature infant; surgery; vascular ring.

Percutaneous closure of small patent arterial ducts using occluding spring coils and a snare

1996 ◽  
Vol 6 (4) ◽  
pp. 327-331 ◽  
Author(s):  
Benjamin Zeevi ◽  
Michael Berant ◽  
Galit Bar-Mor ◽  
Leonard C. Blieden
Keyword(s):  
Transcatheter Closure ◽  
Color Doppler ◽  
Percutaneous Closure ◽  
Surgical Ligation ◽  
Residual Lesion ◽  
Arterial Duct ◽  
The Mean ◽  
Patent Arterial Duct ◽  
Spring Coil

AbstractIn recent years, the percutaneous closure of small and medium-sized patent arterial ducts has been achieved using occluding spring coils. We describe our experience in 33 patients with this technique using a snare to facilitate the procedure. All patients had a clinically apparent patent arterial duct and underwent an attempt at transcatheter closure at a mean age of 5.6 years. In one patient, the duct was a residual lesion following surgical ligation, and in three was residual following attempted closure with a Rashkind double-umbrella. The mean narrowest diameter of the ducts was 1.9 mm. The coil embolized in two of the first four patients, and subsequent to that experience we used a snare to improve delivery. Of the 33 patients, implantation was successful in 32 (97%) using one [29 patients] or two [two patients] coils and in one by a combination of a double-umbrella device and an occluding spring coil. The mean fluoroscopic screening time for the whole group was 26.5 minutes, this time decreasing to 18.5 minutes in the last 26 patients [p <0.05]. Color-Doppler echocardiogram performed the morning after placement of the coils has shown residual leaks in nine of 32 patients [28%]. At a mean follow-up of 7.6 months, repeated imaging has shown residual leaks in four of these patients [12.5%]. No patient had a residual continuous murmur immediately following occlusion. Based on our results, we conclude that occlusion of small to medium-sized ducts using coils appears to be effective. The use of a snare to hold and manipulate the coil as it is delivered improves both control of the coil and the accuracy of its placement.

Surgical ligation of a residually patent arterial duct following failed occlusion using transcatheter coils

2003 ◽  
Vol 13 (6) ◽  
pp. 574-575 ◽  
Author(s):  
Derek S. Wheeler ◽  
James Matthew Maxwell ◽  
W. Bradley Poss
Keyword(s):  
Heart Disease ◽  
Premature Infants ◽  
Pediatric Cardiology ◽  
Large Diameter ◽  
Structural Heart Disease ◽  
Comparable Efficacy ◽  
Surgical Ligation ◽  
Arterial Duct ◽  
Low Weight ◽  
Patent Arterial Duct

Transcatheter techniques for occlusion of the persistently patent arterial duct using coils have become standard therapy at many centers for pediatric cardiology, and in selected patients have demonstrated comparable efficacy to surgical ligation. Surgical ligation may still be required in many cases, including premature infants or those born with low weight, those with ducts of large diameter, those with associated structural heart disease, and in circumstances of unsuccessful occlusion subsequent to attempted closure using coils. We report on the successful surgical ligation of an arterial duct of moderate size that exhibited residual patency despite two separate attempts at occlusion using coils.

Difficulties generated by the small, persistently patent, arterial duct

1999 ◽  
Vol 9 (4) ◽  
pp. 392-395 ◽  
Author(s):  
Brigitte Raaijmaakers ◽  
Aagje Nijveld ◽  
Anton van Oort ◽  
Ronald Tanke ◽  
Otto Daniëls
Keyword(s):  
Heart Surgery ◽  
Transcatheter Closure ◽  
Open Heart Surgery ◽  
Clinical Findings ◽  
Open Heart ◽  
Transcatheter Intervention ◽  
Surgical Ligation ◽  
Arterial Duct ◽  
Catheter Closure ◽  
Patent Arterial Duct

AbstractOver recent years, echo-Doppler cardiography has shown that a small, sometimes silent, arterial duct exists in more patients than previously recognized. To know the incidence of an arterial duct subsequent to therapy, we studied retrospectively our patients undergoing open-heart surgery and surgical or catheter closure. Three groups of patients were studied: those with patency of the duct subsequent to open heart surgery without any sign of patency before or during surgery, those with persistent duct after surgical ligation and those with persistent patency after attempted catheter occlusion with the Rashkind device. In the first group (of 431 children) four (0.9%) had persistence of this duct, of which three were silent. In the second group, patency persisted in four of 100 patients (4%), three being silent. In the last group there were five persisting shunts, three producing no murmur, in 30 patients (17%). We compared our results with those reported in the literature and conclude that echo-Doppler cardiography is needed to detect persistent shunting across a duct after therapy, since most of the residual ducts in this study were silent. This means that clinical findings alone cannot be relied upon, and careful echo-Doppler cardiography is essential. Also, the process of closure of a persistent duct by surgical ligation or transcatheter intervention is no guarantee of success. The risk of infective endocarditis is important in such persistent ducts and, at present, it is unknown either for a small, silent duct or in a persistent duct that remains open after attempted transcatheter closure, but now is in association with a foreign body.

Complete transcatheter closure of a patent arterial duct with subsequent haemolysis

2010 ◽  
Vol 20 (04) ◽  
pp. 462-464 ◽  
Author(s):  
Neven Cace ◽  
Vladimir Ahel ◽  
Iva Bilic
Keyword(s):  
Transcatheter Closure ◽  
Arterial Duct ◽  
Patent Arterial Duct

scholarly journals Device closure of patent ductus arteriosus: analysis of cases in a Bangladeshi centre

2020 ◽  
Vol 7 (7) ◽  
pp. 1481
Author(s):  
Nurun N. Fatema ◽  
Abul K. M. Razzaque
Keyword(s):  
Patent Ductus Arteriosus ◽  
Transcatheter Closure ◽  
Ductus Arteriosus ◽  
Age Groups ◽  
Device Closure ◽  
Catheterization Laboratory ◽  
Congenital Rubella ◽  
First Choice ◽  
Associated Conditions ◽  
Patent Ductus

Background: Transcatheter closure of Patent ductus arteriosus (PDA) has become the first-choice therapy for closure in patients of any age group. Authors reviewed the outcome of device closure in all age groups starting from neonate to adult.Methods: From December 2014 to December 2019, 440 cases underwent transcatheter closure in a catheterization laboratory of a tertiary level cardiac hospital. Selection criteria were isolated PDA or PDA with associated conditions which can be managed in the same setting by an intervention. Exclusion criteria were proven Eisenmenger syndrome. A retrospective review of outcome and complications were recorded from computerized data records.Results: Age of the patient varied from 10 days to 65 years. The median age was 3 years. Most of the patients were female (63%), weight varied from 1.8 kg to 75 kg. the median weight was 7.5 kg. Isolated PDA cases were 74.77 %. Among syndromes, congenital rubella syndrome was common (7.5%), followed by Down Syndrome (6.36%). The narrowest PDA diameter varied for 1.8 mm - 14 mm with a median of 5 mm. Among duct occluders, 8x6 mm CeraTM was the commonest one used in the study population. Complete occlusion was observed in 99.55% of cases.Conclusions: Transcatheter closure of PDA is considered safe and efficacious in all age groups. It is the gold standard now and replaced surgical option in most of the places.

Comparison of two transcatheter closure methods of persistently patent arterial duct

2001 ◽  
Vol 87 (1) ◽  
pp. 76-81 ◽  
Author(s):  
Henri Justino ◽  
Robert N Justo ◽  
Caroline Ovaert ◽  
Alan Magee ◽  
Kyong-Jin Lee ◽  
...  
Keyword(s):  
Transcatheter Closure ◽  
Arterial Duct ◽  
Patent Arterial Duct

scholarly journals Severe Spinal Cord Ischemic Injury Secondary to Device Embolization after Transcatheter Closure of a Patent Arterial Duct

2014 ◽  
Vol 41 (1) ◽  
pp. 83-86
Author(s):  
Liang Tang ◽  
Shenghua Zhou ◽  
Xiangqian Shen
Keyword(s):  
Spinal Cord ◽  
Medical Literature ◽  
Transcatheter Closure ◽  
Ischemic Injury ◽  
Descending Thoracic Aorta ◽  
Arterial Duct ◽  
Device Embolization ◽  
Device Deployment ◽  
Patent Arterial Duct ◽  
Pathophysiologic Mechanisms

Percutaneous closure of patent arterial ducts with the Amplatzer Ductal Occluder has become an effective and widely accepted alternative to surgical management. Although rarely, the occluder can be dislodged after an initially successful deployment, and with catastrophic consequences. We describe such a case in a 12-month-old girl who underwent transcatheter closure of a patent arterial duct. After device deployment, the occluder embolized in the patient's descending thoracic aorta, and severe spinal cord ischemic injury resulted. To our knowledge, ours is the first report of this complication after the deployment of an Amplatzer Ductal Occluder. We discuss pathophysiologic mechanisms that could expose patients to the risk of device dislodgment, and we review the relevant medical literature.

scholarly journals The Role of Natriuretic Peptides in Management of Premature Infants with Hemodynamically Significant Patent Arterial Duct

2019 ◽  
Vol 18 (1) ◽  
pp. 8-12
Author(s):  
Evgenij G. Furman ◽  
Aleksej N. Biyanov ◽  
Artem Porodikov ◽  
Oksana B. Bahmet’eva ◽  
Vladimir G. Druzhen’kov
Keyword(s):  
Premature Infants ◽  
Natriuretic Peptides ◽  
Prognostic Value ◽  
Neonatal Period ◽  
Management Planning ◽  
Arterial Duct ◽  
Life Threatening ◽  
Complications And Mortality ◽  
Patent Arterial Duct

Hemodynamically significant patent arterial duct in premature infants can be the reason of life-threatening complications. Thus it is topical to define the high risk of such complications and mortality in early neonatal period. We have reviewed researches results covering prognostic value of natriuretic peptides level in premature infants with hemodynamically significant patent arterial duct. The data on management planning of such patients according to the A-type and B-type natriuretic peptides levels is presented.

Sign in / Sign up

Export Citation Format

Share Document